- Sections
- C - Chimie; métallurgie
- C12N - Micro-organismes ou enzymes; compositions les contenant; culture ou conservation de micro-organismes; techniques de mutation ou de génétique; milieux de culture
- C12N 7/04 - Inactivation ou atténuation; Production de parties élémentaires de virus
Détention brevets de la classe C12N 7/04
Brevets de cette classe: 1122
Historique des publications depuis 10 ans
58
|
61
|
74
|
53
|
65
|
65
|
65
|
41
|
43
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
20 |
Intervet International B.V. | 1282 |
16 |
Centre National de La Recherche Scientifique | 10091 |
14 |
Institut Pasteur | 789 |
12 |
Xiamen University | 515 |
12 |
The Regents of the University of California | 19503 |
11 |
Icahn School of Medicine at Mount Sinai | 900 |
11 |
Medicago Inc. | 179 |
10 |
The Research Foundation for The State University of New York | 1550 |
9 |
Cytos Biotechnology AG | 25 |
8 |
PnuVax Incorporated | 14 |
8 |
Boehringer Ingelheim Animal Health USA Inc. | 495 |
8 |
Boehringer Ingelheim Vetmedica GmbH | 1289 |
7 |
Massachusetts Institute of Technology | 9912 |
7 |
The Broad Institute, Inc. | 1706 |
7 |
CEVA Sante Animale | 689 |
7 |
Xiamen Innovax Biotech Co., Ltd. | 86 |
7 |
Zoetis Services LLC | 1549 |
7 |
Novartis AG | 11276 |
6 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
6 |
Autres propriétaires | 929 |